Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients with Refractory Advanced/Metastatic Microsatellite Stable Colorectal Cancer

Disease Sites:

Not Available

Staging:

Phase II

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Not Available

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

02-18-2026

Trial Type:

Treatment

Protocol ID:

VICCGI25032

National Clinical Trial ID:

NCT06992258

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available